Marbofloxacin EP Impurity F

Stability-Indicating Liquid Chromatography–Spectrophotometric UV Method for the Simultaneous Determination of Marbofloxacin, Dexamethasone and Clotrimazole in a Liquid Pharmaceutical Dosage Form
Simona De Robertis1 · Lisa Elviri1 · Annalisa Bianchera1 · Ruggero Bettini
Chromatographia (2015) 78:1299–1304
 
Development and validation of HPLC assay method for marbofloxacin determination in veterinary chewable tablets
K. R. W. Oliveiraa , R. A. Sversuta , A. K. Singhb , M. S. Amaralc and N. M. Kassab
Acta Chromatographica 31(2019)4, 291–293
 
Pharmacokinetics and tissue residues of marbofloxacin in crucian carp (Carassius auratus) after oral administration
Yanlei Zhu  Yeping Tan  Chunmei Wang  Nan Zhang  Yunping Liu  Lina Liu  Chunming Li  Xiaocong Lu  Jiyue Cao
Aquaculture Research, 2009, 40, 696-709

Marbofloxacin EP Impurity F is chemically 4-[6-Carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[3,2,1-ij][4,1,2]benzoxadiazin-10-yl]-1-methylpiperazine 1-oxide (as per EP). It is also known as Marbofloxacin N-oxide. Marbofloxacin EP Impurity F is supplied with detailed characterization data compliant with regulatory guideline. Marbofloxacin EP Impurity F can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Marbofloxacin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.